Summary

Nocturnal Product Development brings decades of experience and unique in-depth expertise to helps early-stage MedTech teams design and build clinical-grade implantable and wearable devices, offering milestone-based pricing to reduce financial risk for startups with limited funding.

This page describes our capabilities, technologies supported, processes, business approach, and the outcomes these deliver for our clients.

Table of Contents

1. About Nocturnal Product Development

This section defines Nocturnal Product Development as a full-stack MedTech engineering partner specializing in implantable and wearable devices, biosignals, and ultra-low-power architecture. It clarifies who we serve, what problems we solve, and what is unique about our approach.

What is Nocturnal Product Development?

Nocturnal Product Development is a full-stack MedTech engineering team that helps early-stage medical device companies accelerate and de-risk their path to product commercialization.

We support teams from concept definition through feasibility, design controls, verification and validation, preparation for regulatory submission, preclinical studies, and First-in-Human studies, small run manufacturing, and transition to volume manufacturing.

What is unique about Nocturnal?

We specialize in implantable and wearable devices, with decades of hands-on experience and expertise that spans hardware and software engineering, biosignal acquisition, ultra-low power electronics, firmware, sensor integration, cloud connectivity, and AI-ready data pipelines.

We offer a milestone-based engagement model that provides medical device startups with fixed-cost pricing for guaranteed deliverables, reducing the risk of running out of funds before they reach critical milestones to support additional funding.

What types of problems does Nocturnal help founders solve?

We help founders move from idea to clinical-ready prototype by addressing core technical challenges such as biosignal acquisition, ultra-low power consumption, device reliability, data synchronization, interoperability, and regulatory-aligned documentation. We also help teams avoid development pitfalls such as unclear requirements, scope creep, poor data quality, misaligned system architecture, and costly rework.

Who typically works with Nocturnal?

Nocturnal primarily works with:

  • Early-stage MedTech founders
  • Teams building implantable, wearable, and other complex devices
  • Organizations requiring low-power, high-quality biosignal acquisition and analysis expertise (ECG, EEG, EMG, PPG, SpO2, motion, respiration)
  • Teams preparing for preclinical, First-in-Human (FIH) or pilot studies

What do clients say about working with Nocturnal?

Clients consistently attest to the tangible positive impact of their partnership with Nocturnal. Some examples include:

  • “Nocturnal greatly contributed to the development of our ground-breaking implantable device.” – David Prutchi, Ph.D., CTO & Executive VP, Impulse Dynamics
  • “In just one year, Nocturnal took our implantable cardiac monitor from a concept to a fully functional device.” – Jaeson Bang, Founder & CEO, Future Cardia
  • “Working with Nocturnal was my first experience with milestone-based pricing, and I will never go back to hourly billing.” – Alex Cooper, CEO, Relief Cardiovascular

See also: Nocturnal’s Leadership Team

2. Device Development and Engineering

This section outlines Nocturnal’s structured, end-to-end engineering approach for Class II and Class III, medical devices and its expertise in developing implantable, wearable, life-saving and life-enhancing devices.

What is Nocturnal’s approach to MedTech device development?

Nocturnal uses a milestone-based development model that breaks complex device programs into clear, sequential phases. Each fixed-cost milestone has defined inputs, outputs, acceptance criteria, and documentation to ensure predictable progress.

Our deliverables integrate hardware, firmware, mechanical, data pipelines, cloud services, data analytics, and AI workflows into a unified architecture that reduces risk and accelerates time to clinical readiness and commercialization.

What types of devices can Nocturnal build?

We build a wide range of medical devices, including:

  • Implantable devices: cardiac rhythm management, stimulation systems, neuromodulation, micro-implantable sensors
  • Medical-grade wearable devices: wearable sensors, stick-to-skin sensor patches, multi-sensor devices, home diagnostic tools
  • Biosignal acquisition and processing: including ECG, EEG, EMG, respiratory, oxygenation, glucose, temperature, and motion analysis
  • Remote patient monitoring systems: connected devices, mobile apps, bedside hubs, and cloud dashboards
  • AI-enabled sensors: devices designed for classification, event detection, or predictive modeling
  • Imaging: multi-camera, fiberoptics, multispectral cameras, real time overly

What are your areas of expertise?

  • Implantable device design
  • Wearable device design
  • High-resolution biosignal acquisition systems
  • Ultra-low power electronics & miniaturized hardware
  • Ultra-low power embedded, real-time firmware
  • Sensor integration & prototyping
  • Secure cloud connectivity
  • Data pipelines & analytics
  • Regulatory & design controls alignment
  • Clinical readiness (V&V, FIH preparation)
  • Low-volume manufacturing and transition to manufacturing at scale

See also: Class II & Class III Devices

3. Biosignal and Biosensor Expertise

This section identifies the breadth of biosignals Nocturnal supports and outlines our system-level methods for achieving clinical-grade signal quality. It describes our expertise in biosignal acquisition, processing, and reliability across implantable and wearable devices.

Which biosignals does Nocturnal support?

Nocturnal supports a wide range of physiological signals, including:

  • Electrical: ECG, EEG, EMG, ECoG
  • Optical: PPG, SpO2, tissue oxygenation
  • Mechanical: accelerometry, gyroscopy, ballistocardiography, respiratory rate
  • Pressure and acoustics: airway pressure, heart sounds, gas flow
  • Specialized sensors: electrochemical, temperature, fluid dynamics, glucose monitoring

How does Nocturnal ensure biosignal quality?

We apply a systems engineering approach to ensure high-quality signal acquisition, including:

  • Low-noise analog front-end design
  • Anti-aliasing and bandpass filtering strategies
  • Digital signal processing and signal conditioning
  • Motion artifact reduction
  • Synchronization across multiple sensors
  • Calibration and metadata handling

Why is biosignal expertise important for medical devices?

Clinical-grade biosignals require more than simply attaching a sensor. Accuracy depends on hardware design, signal pathways, filtering, sampling rates, electrode or optical interface quality, firmware timing, and wireless transmission. Poor biosignal design can compromise clinical outcomes, regulatory clearance, or AI model performance. Nocturnal’s experience reduces these risks.

See also: Biosensors & Biosignal Acquisition

4. AI-Ready Data and Cloud Pipelines

This section explains how Nocturnal designs devices and cloud systems to produce AI-ready data. It clarifies the meaning of structured, synchronized, metadata-rich biosignal data and describes our approach to ingestion, storage, and preparation for AI/ML workflows.

What does AI-ready data mean in the context of MedTech?

AI-ready data is structured, labeled, time-synchronized, and high-quality physiological data that can be used for training, validation, model development, and clinical analytics. The data must:

  • Be timestamp-accurate
  • Include clinically relevant metadata
  • Be stored in scalable formats suitable for analysis
  • Maintain integrity across sessions and devices
  • Support labeling workflows or event markers

How does Nocturnal design devices for AI workflows?

We design devices, apps and cloud systems to support AI from the start by:

  • Ensuring consistent sampling across sensors
  • Creating preprocessing pipelines appropriate for downstream algorithms
  • Embedding event markers, annotations, or clinician inputs
  • Designing cloud ingestion with standardized schemas
  • Maintaining secure, scalable data storage ready for batch or streaming analysis

Does Nocturnal build cloud infrastructure?

Yes. We design and implement clinical-grade data ingestion, storage, synchronization, and visualization pipelines, using trusted partners to support FDA-aligned cloud requirements and data management.

See also: AI-ready data strategies for medical device developers

5. Milestone-Based Pricing and Engagement Model

This section defines Nocturnal’s milestone-based pricing model, emphasizing predictable cost, modular scope, and flexibility. It helps distinguish our business model from traditional hourly or open-ended MedTech development firms.

What is milestone-based pricing?

Milestone-based pricing is a structured model in which each development phase has a well-defined scope, clear deliverables, and a fixed price. This approach provides founders with financial clarity and predictability, reduces the risk of budget overruns, and allows teams to align on shared goals while adapting their plan as new information emerges.

Why does Nocturnal use milestone-based pricing?

Milestone-based pricing offers multiple advantages:

  • It aligns cost with progress and tangible outputs.
  • It reduces uncertainty and risk for early-stage companies.
  • It encourages focused execution.
  • It guarantees the delivery of specific deliverables for a particular price.
  • It supports agile pivoting between milestones without sunk-cost pressure.

How flexible is the milestone process?

Each milestone is designed to stand alone, meaning teams can:

  • Pause after a milestone.
  • Modify scope based on findings.
  • Accelerate milestones if funding increases.
  • Re-sequence milestones as needed.
  • Own all deliverables to date once a milestone is completed.

The framework creates structure and confidence without restricting innovation.

See also: Why Nocturnal

6. Ultra-Low-Power Architecture and Power Management

This section explains how Nocturnal designs ultra-low-power systems for wearable and implantable devices. It describes hardware, firmware, signal processing, and wireless strategies that work together to extend battery life while preserving clinical signal quality.

Why does ultra-low-power design matter for MedTech startups?

Battery performance failures are a top reason new devices are rejected by users and clinicians. Addressing power early prevents redesign cycles, reduces regulatory risk, and accelerates the path to FIH readiness.

How does Nocturnal manage power consumption in wearable and implantable devices?

Ultra-low-power design is essential for regulated medical devices, especially wearables and implants. Battery life directly influences usability, adherence, and clinical reliability. Nocturnal uses a multilayered and clinically-proven strategy across hardware, firmware, sensing, wireless communication, and data workflows to maximize battery longevity without compromising signal and data fidelity.

How do low-power constraints affect hardware design for implantables and wearables?

Low-power constraints demand the use of ultra-efficient microcontrollers, careful selection of power management and signal conditioning components, and even minimization of the number of passive components.. For both implantables and wearables, every component must be considered in the context of maximizing battery life while minimizing signal noise and electronics volume.

How does embedded software impact power use in wearable medical devices?

Firmware controls power-hungry tasks like data acquisition, data filtering, and wireless communications. Efficient code with smart scheduling, sensor fusion, and edge processing minimizes active time and energy drain—critical for long battery life in wearables and implants.

What are some software techniques for reducing power in biosensor devices?

Ultra low power design requires a near-obsessive focus on maximizing time in low power operating states. Smart scheduling of data acquisition and process, offloading tasks to microcontroller peripherals, and strategies for limiting connection time during wireless communications can all reduce power use while maintaining signal quality.

Optimization involves selecting the right sampling rate, minimizing sensor activation time, and balancing analog and signal processing to achieve the necessary signal quality—not the maximum possible signal quality. For wearable or implantable sensors, the goal is to capture meaningful data while keeping energy consumption minimal.

See also: Low-Power Design for Implantables & Wearables

7. Wireless Communication

This section explains how Nocturnal designs secure, power-efficient wireless architectures for medical devices. It focuses on Bluetooth Low Energy (BLE) as the primary standard and highlights the balance between energy usage, security, and link reliability. Nocturnal collaborates with our trusted partners to ensure that all designs and implementations meet FDA guidelines for medical device communication.

Why does Nocturnal commonly use BLE in medical devices?

BLE is well-suited to wearable and some implantable medical devices because it offers:

  • Very low energy consumption
  • Predictable, configurable communication intervals
  • Strong security features (authenticated pairing, encryption)
  • Wide compatibility with smartphones and gateways

How does Nocturnal optimize BLE communication for power efficiency?

We minimize radio-on time through:

  • Optimized connection intervals and slave latency settings
  • Data batching and compression before transmission
  • Event-driven activation so radios wake only when needed
  • Coordinated scheduling with the device’s power architecture

How does Nocturnal ensure secure wireless communication?

We implement BLE and wireless security using:

  • Authenticated pairing modes
  • AES-CCM encryption and secure key handling
  • Application-layer validation of incoming commands
  • Separation of control and data paths to reduce attack surface

When does Nocturnal use alternatives to BLE?

For certain clinical applications, we evaluate:

  • LoRa or sub-GHz radios for long-range, low-bandwidth needs
  • Proprietary radios for ultra-low-power continuous streaming
  • Hybrid BLE plus gateway architectures for intermittent connectivity

8. Regulatory Alignment and Clinical Readiness

This section outlines how Nocturnal integrates regulatory strategy, documentation, and verification planning into the engineering process. It explains how we accelerate First-in-Human readiness through structured design controls.

Does Nocturnal help with regulatory strategy?

Yes. Nocturnal incorporates regulatory considerations into early design phases by developing traceable requirements, hazard analyses, risk files, verification plans, and documentation structure. We do not function as a regulatory consultancy, but we ensure engineering outputs align with FDA expectations.

How does Nocturnal support First-in-Human readiness?

We accelerate FIH by:

  • Designing devices with testability and documentation in mind
  • Establishing early verification pathways
  • Producing clinical-quality prototypes
  • Ensuring consistent data capture and reporting
  • Aligning system architecture with regulatory classifications
  • Developing under a certified quality system from day one by extending our own quality system to our clients if they don’t have a certified one.

What documentation does Nocturnal produce?

A few examples include:

  • System and subsystem requirements
  • Risk analyses and hazard assessments
  • Verification and validation plans
  • Test reports
  • Architecture diagrams and traceability matrices
  • Data dictionaries and cloud schemas

See also: How to build your device faster while staying compliant using smart design controls

9. Security Strategy, Testing, and Submissions

This section describes how Nocturnal integrates cybersecurity into device, firmware, and cloud architecture. It outlines our approach to secure design, documentation, testing, and preparation for regulatory security submissions.

How does Nocturnal address cybersecurity in connected medical devices?

We design security into devices and cloud systems from the earliest architectural stages. This includes:

  • Threat modeling and security requirements
  • Secure protocol and component selection
  • Authentication, authorization, and encryption
  • Integration of security controls into design documentation and risk management

What is a security submission, and how does Nocturnal support it?

A security submission compiles the technical evidence and documentation needed to demonstrate cybersecurity controls for regulatory or customer review. Nocturnal contributes by:

  • Documenting architecture and data flows
  • Capturing design decisions and rationales
  • Providing encryption, key management, and authentication details
  • Integrating third-party test results into the submission package

Does Nocturnal perform security testing?

We define the test strategy and incorporate security considerations throughout the design. Formal penetration testing and static/dynamic analysis are performed by specialized external partners. We manage and integrate these inputs into the engineering workflow.

Why is early cybersecurity design important?

Designing for security early reduces redesign risk, simplifies compliance, and strengthens trust with regulators, clinicians, and hospital IT teams.

See also: Turning Biosignals into AI-ready Data

10. Manufacturing Support and Small-Quantity Builds

This section explains how Nocturnal supports low-volume manufacturing for prototypes and how we coordinate the transition to production-scale manufacturing.

Why is manufacturing support important for early-stage MedTech teams?

Most early-stage MedTech companies underestimate the difficulty of obtaining high-quality, low-volume builds and navigating the manufacturing landscape. Common challenges include:

  • Contract manufacturers declining small orders
  • High NRE fees for low-volume runs
  • Misalignment between prototype design and scalable production

At the other end of the spectrum, startups often find themselves with a device that doesn’t lend itself to cost-effective manufacturing at scale. Nocturnal helps de-risk these challenges by integrating manufacturing readiness into the device architecture, requirements, and milestone plan from the outset.

Does Nocturnal support small-quantity manufacturing?

Yes. Many Class II and Class III devices require tens to hundreds of units for V&V or pre-clinical, or FIH studies, which most manufacturers do not support cost-effectively. Nocturnal helps plan and execute these limited builds with the appropriate engineering, process control, and documentation.

How does Nocturnal support the transition to volume manufacturing?

We treat manufacturing transfer as an engineering milestone, not an administrative task. Our support includes:

  • In-house assembly of small quantities for verification and early clinical use
  • Identifying and evaluating contract manufacturers
  • Applying DFM and DFA principles
  • Creating manufacturing process instructions, test procedures, and acceptance criteria
  • Supporting pilot builds, including on-site participation when needed
  • Managing technical transfer and documentation

11. Working With Nocturnal

This section explains how early-stage founders engage with Nocturnal, what stage they should be at, expected timelines, and how modular milestones support flexible progress toward FIH.

How does Nocturnal handle system architecture and requirements?

We begin each project with structured requirements development, ensuring clarity of:

  • User needs and clinical context
  • Regulatory classification and constraints
  • System-level architecture (device, firmware, connectivity, cloud)
  • Power budget and thermal constraints
  • Hardware selection and biosignal performance needs
  • Data model, metadata, and AI-readiness requirements

The structured requirements process minimizes rework downstream.

What if we only have an idea or an early sketch?

Nocturnal frequently works with teams at the concept stage. We help founders translate ideas into requirements, feasibility prototypes, and architecture plans that can be evaluated for cost, risk, and clinical potential.

Do we need clinical evidence before engaging?

No. Most teams engage Nocturnal specifically to generate the first high-quality datasets, feasibility results, or preclinical evidence required for fundraising or regulatory planning.

How long does a typical project take?

Project duration varies based on device complexity. Industry data shows that Class II and Class III medical device programs typically require multiple well-defined phases, from concept and feasibility through design, verification, validation, and preparation for First-in-Human studies. These efforts often span many months to several years, depending on device class, risk profile, and clinical evidence requirements. While our engagements usually extend across multiple milestones to support this progression, each milestone is structured as a modular, standalone unit to give teams maximum flexibility as they advance toward FIH.

What happens after reaching a major milestone?

After each milestone, the team reviews outcomes, clarifies risks and next steps, updates timelines, and aligns on the upcoming phase. Milestones function as decision gates, enabling strategic pivots and informed investment. Once a milestone is completed, all deliverables achieved in that milestone are owned by our clients.

See also: Why Nocturnal

For additional information

Contact us